期刊文献+

HPLC-UV检测法及其在比格犬血浆非布司他浓度检测中的应用 被引量:1

HPLC-UV and its application in detection of plasma concentration of febuxostat in Beagle
下载PDF
导出
摘要 目的建立测定比格犬血浆非布司他浓度的高效液相色谱紫外(HPLC-UV)检测法。方法采用冰醋酸和乙腈对500μL比格犬血浆进行蛋白沉淀,离心后取上清液20μL进样分析。采用反相C18液相色谱柱(250mm×4.6mm,5μm)进行检测;流动相为甲醇-水(90∶10,V/V),流速1.0 mL/min,紫外检测波长为314nm。结果非布司他色谱峰的保留时间为4.50min,标准曲线在0.27~16.32μg/mL浓度范围内线性关系良好,平均相关系数(r)=0.999 5±0.002 0。日内和日间的精密度均不超过7.0%;准确度分别为96.7%~104.2%、97.7%~105.4%。结论 HPLC-UV检测法简单、准确、可靠,可用于非布司他药代动力学研究。 Objective To establish a high performance liquid chromatography-ultraviolet(HPLC-UV) assay for detecting plasma concentration of febuxostat in Beagle. Methods 500 /xL Beagle plasma sample was subjected to protein precipitation using glacial acetic acid and acetonitrile, and analysis was performed on 20uL supernatant after centrifugation. Reversed-phase C18 HPLC column (250.0 mmX4.6 mm,5 um) was applied with mobile phase consisted of methanol-water (90 : 10V/V) at a flow rate of 1.0 mL/min,the UV detection wavelength was set at 314 nm. Results Retention time of febuxostat chromatographic peak was 4.50 min. The standard curve was linear over the concentration range of 0.27-- 16.32/xg/mL with average correlation coefficient of 0. 999 5~0. 002 0. The relative standard deviations of intra and inter-day assay variations were less than 7.0~/00, and the accuracy were 96.7% -- 104.2%, 97.7% -- 105.4 %, respectively. Conclusion HPLC UV assay is simple, accurate and reliable, which can be applied to investigate the pharmacokinetics of febuxostat.
作者 龙波 苏湲淇
出处 《重庆医学》 CAS CSCD 北大核心 2013年第1期49-50,53,共3页 Chongqing medicine
基金 2010年重庆医药高等专科学校科研课题基金资助项目(2009106)
关键词 色谱法 液相 分光光度法 紫外线 药代动力学 非布司他 chromatography, liquid spectrophotometry, ultraviolet pharmacokinetics febuxostat
  • 相关文献

参考文献8

二级参考文献21

  • 1张媛.抗痛风药Febuxostat[J].药学进展,2005,29(3):141-142. 被引量:8
  • 2US FDA. FDA approves drug for gout management [ EB/ OL]. [2009 -02 - 13 ]. http://www, fda. gov/News Events/Newsroom/PressAnnoun Cements/ucm149534. hun. 被引量:1
  • 3EMEA. EPARs for authodsed medicinal products for humanuse[ EB/OL]. [ 2008 - 04 - 11 ]. http ://www. emea. europa. htm. EPAR/adenuricJ adcnurie. 被引量:1
  • 4KONDO S, FUKUSHIMA H, HASEGAWA M, et al. 2- Arylthiazole derivative and pharmaceutical composition con- taining the same:EP,0513379[ P]. 1992 - 11 - 19. 被引量:1
  • 5KONDO S, FUKUSHIMA H. 2-Arylthiazole derivatives and pharmaceutical composition thereof: US,5614520 [ P ]. 1997 - 03 - 25. 被引量:1
  • 6OKAMOTO K, EGER B T, NISHINO T. An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enayme-inhibitor complex and mechanism of inhibition [ J]. J Biol Chem, 2003,278 ( 3 ) : 1848 - 1855. 被引量:1
  • 7KOMORIYA K, OSADA Y, HASEGAWA M, et al. Hypouricemic effect of allopurinol and the novel xanthine oxidase inhibitor TEI-6720 in chimpanzees [ J ]. European Journal of Pharmacology, 1993,250: 455 - 460. 被引量:1
  • 8BECKER M A,SCHUMACHER H R,WORTMANN R L, et al. Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase [ J ]. Arthritis & Rheumatism,2005,52(3) :916-923. 被引量:1
  • 9BECKER M A, SCHUMACHER H R, WORTMANN R L. Febuxostat compared with allopurinol in patients with hypemricemia and gout[ J]. N Engl J Med,2005, 353 (23) :2450 - 2461. 被引量:1
  • 10CHOI HK, MOUNT DB, REGINATO AM. Pathogenesis of gout [J]. Ann Intern Med, 2005, 143(7): 499-516. 被引量:1

共引文献46

同被引文献11

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部